Patienter, der i henhold til tumorstatus, Karnofsky- performance- status (KPS) og alder, havde en god prognose, havde større gavn af behandlingen, når cetuximab blev givet sammen med strålebehandling.
Patients with a good prognosis as indicated by tumour stage, Karnofsky performance status (KPS) and age had a more pronounced benefit, when cetuximab was added to radiation therapy.